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ABSTRACT  
The medicinal plants are important source for pharmaceutical manufacturing. Medicinal plants & herbal medicines account for a  significant 
percentage of the pharmaceutical market. There is increasing awareness and general acceptability of the use of herbal drugs i n today’s medical 
practice although most of these applications are not scientific. Herbal medicines are not a simple task since many factors influence the 
biological efficacy and Reproducible therapeutic effect. So it is necessary to improve safety of herbal drugs by developing certain quality control 
parameters & by following the WHO guidelines for herbal medicines. This review seeks to enlighten the need to establish quality parameters for 
collection, handling, processing and production of herbal medicine as well as employ such parameters in ensuring the safety of the global herbal 
market. It is necessary to introduce measures on the regulation of herbal medicines to ensure quality, safety, efficacy of herbal medicines by 
using modern suitable standards & GMP. The processes of good quality assurance and standardization of herbal medicines and products using 
various spectroscopic, chromatographic and electrophoretic methods were also discussed. In fact, the research field of quality control of herbal 
medicines is really an interdisciplinary research. It needs crossover of chemistry, pharmacology, medicine and even statistics to provide a 
platform for the quality control of traditional herbal medicines and further to discover the novel therapeutics composed of multiple chemical 
compounds. 
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Introduction 
Standardization of herbal drugs is the process of evaluation 
the quality and purity of crude drug by means of various 
parameter like morphology, physical, chemical and 
biological observation.’’1 
Need of standardization: - In recent years there is a spurt 
in the interest regarding survival of ayurvedic forms of 
medication. In the global perspective, there is a shift towards 
the use of medicine of herbal origin. As the dangers and the 
shortcoming of modern medicine have getting more 
apparent, majority of Ayurvedic formulation are prepared 
from herbs2.It is the cardinal responsibility of the regulatory 
authorities to ensure that the consumers get the medication, 
which guarantee. Purity, safety, potency and efficacy. WHO 
has emphasized the need to ensure quality control of 
medicinal plant products by using modern technique and by 
applying suitable parameters and standards3.  
Current Regulation for standardization of crude drugs:-
In India a great deal of bulk knowledge exists among 
ordinary people about the traditional use of herbal medicine. 
It is difficult to quantify the market size of the traditional 
Indian system. Since most practitioners formulate and 
dispense their own recipes4.The present annual turnover of 
product manufactured by large companies is estimated at 
approximately US$300 million compared to a turnover of 
approximately US$2.5 billion for modern drugs. According to 
the study on the attitude of modern medicine practitioners 
are relatively unfamiliar with Ayurvedic product even 
though some are practiced. They are willing to try an 
Ayurvedic product if it efficiency disease. Liver and skin 
disease5.  
Conventional Methods For Standardization Of Crude 
Drug :-Standardization of herbal raw drug includes passport 
data of raw plant drugs. It includes medico-botanical survey, 
identification, botanical authentification, macroscopic, 
examination. Testing of drugs as per approved 
Pharmacopoeial testing protocol- Fully pharmacognostical 
profile, Identification by various chromatographic 
techniques, Assessment of purity by physico-chemical 
profile, Assessment of strength by active marker or assay 
estimation and Safety by heavy metal profiling, 
microbiological limit test analysis, aflatoxins analysis, 
pesticides residue and biological activity6.Further, advances 
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in microscope technology have increased the accuracy and 
capabilities of microscopy as a mean of herbal crude 
material identification due to the implication of light and 
scanning electron microscopes (SEM) in herbal drug 
standardization7-8. 
WHO Guidelines for Quality of Herbal Formulation 
1) Quality control of crude drugs material, plant 
preparations and finished products9. 
2) Stability assessment and shelf life10. 
3. Safety assessment; documentation of safety based on 
experience or toxicological studies11. 
4) Assessment of efficacy by ethno- medical information and 
biological activity evaluations12. 
The bioactive extract should be standardized on the basis of 
active principles or major compounds along with the 
chromatographic fingerprints (TLC, HPTLC, HPLC, and GC). 
Generally, all medicines, whether they are synthetic or of 
plant origin, should fulfil the basic requirement of being safe 
and effective13. The term ‘herbal drugs’ denotes plants or 
plant parts that have been converted into 
phytopharmaceuticals   by means of simple processes 
involving harvesting, drying and storage14.  
Quality Control of Herbal Drugs 
Quality control is a term that refers to processes involved in 
maintaining the quality and validity of a manufactured 
product15. In general, quality control is based on three 
important Pharmacopoeial aspects – 
a. Identity or authenticity- it should have one herb. 
b. Purity – it should not have any contaminant other than 
herb. 
c. Assay or Content -the active constituents should be within 
the defined limits16. 
Identity can be achieved by macro and microscopically 
examinations17. In addition to this identity tests, which 
include simple chemical tests, eg. colour or precipitation and 
chromatographic tests are also necessary. These chemical 
and chromatographic tests help to provide batch to batch 
comparability and the chromatogram may be used as a 
‘fingerprint’ for the herbal ingredient by demonstrating the 
profile of some common plant constituents such as 
flavonoids, alkaloids and terpenes18.  
Stability Assessment And Shelf Life:- Prolonged and 
apparently uneventful use of a substance usually offers 
testimony of its safety. In a few instances, however, 
investigation of the potential toxicity of naturally occurring 
substances widely used as ingredients in these preparations 
has revealed previously unsuspected potential for 
systematic toxicity, carcinogenicity and teratogenicity19. 
Regulatory authorities need to be quickly and reliably 
informed of these findings. They should also have the 
authority to respond promptly to such alerts, either by 
withdrawing or varying the licences of registered products 
containing suspect substances, or by rescheduling the 
substances to limit their use to medicalprescription20. 
Assessment of Quality All procedures should be in 
accordance with good manufacturing practices21. 
Crude Plant Material:-The botanical definition, including 
genus, species and authority, description, part of the plant, 
active and characteristics constituents should be specified 
and, if possible content limits should be defined22. Foreign 
matter, impurities and microbial content should be defined 
or limited. Voucher specimens, representing each lot of plant 
material processed, should be authenticated by a qualified 
botanist and should be stored for at least a 10-yearperiod. A 
lot number should be assigned and this should appear on the 
product label23 . 
Plant Preparations The manufacturing procedure should 
be described in detail. If other substances are added during 
manufacture in order to adjust the plant preparation to a 
certain level of active or characteristics constituents or for 
any other purpose, the added substances should be 
mentioned in the manufacturing procedures.24 A method for 
identification and, where possible, assay of the plant 
preparation should be added. If identification of an active 
principle is not possible, it should be sufficient to identify a 
characteristic substance or mixture of substances to ensure 
consistent quality of the preparation25. 
Finished Product The manufacturing procedure and 
formula, including the amount of excipients, should be 
described in detail. A finished product specification should 
be defined to ensure consistent quality of the product. The 
finished product should be with general requirements for 
particular dosage forms26. 
Stability The physical and chemical stability of the product 
in the container in which it is to be marketed should be 
tested under defined storage conditions and the shelf-life 
should be established27. 
Safety Assessment Herbal medicines are generally 
regarded as safe based on their long-standing use in various 
cultures. However, there are case reports of serious adverse 
events after administration of herbal products. In a lot of 
cases, the toxicity has been traced to contaminants and 
adulteration. However, some of the plants used in herbal 
medicines an also be highly toxic28. As a whole, herbal 
medicines can have a risk of adverse effects and drug-drug 
and drug-food interactions if not properly assessed. 
Assessment of the safety of herbal products, therefore, is the 
first priority in herbal research. These are various 
approaches to the evaluation of safety of herbal medicines. 
Several reports suggest that many herbal products contain 
undisclosed pharmaceuticals and heavy metals29.The 
intentional use of pharmaceutical adulterant is possible. 
Agrochemicals are used to protect the plant from the crude 
plant material. More over mechanism of action, 
pharmacokinetics and drug-drug interactions of many herbs 
are still in infancy. Clinicians should not prescribe or 
recommend herbal remedies without well-established 
efficacy as if they were medications that had been proved 
effective by rigorous study30. 
Assessment of Toxicity investigation will also be required 
because the analysis alone is unlikely to reveal the 
contributions to toxicity itself. In assessing toxicity of an 
herbal medicine, the dose chosen is very important31. 
Toxicity assessment involves one or more of the following 
techniques- In vivo techniques, in vitro techniques, cell line 
techniques, micro- array and other modern technique, 
standardization and techniques to adequately model 
toxicity32. 
Assessment Of Efficacy Herbal medicines are inherently 
different from conventional pharmacological treatments, but 
presently there is no way to assess their efficacy other than 
by currently used conventional clinical trial methodologies, 
in which efficacy is conventionally assessed by clinical, 
laboratory, or diagnostic outcomes33: Clinical outcomes 
include parameters such as improved morbidity, reduced 
pain or discomfort, improved appetite and weight gain, 
reduction of blood pressure, reduction of tumor size or 
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extent, and improved quality of life. Laboratory /other 
diagnostic outcomes include parameters such as reduction 
of blood glucose, improvement of haemoglobin status, 
reduction of opacity as measured by radiological or imaging 
techniques, and improvement in electrocardiogram ECG) 
findings34. 
Microscopic Evaluation: - Full and Accurate 
characterization of plant material requires a combination of 
physical and chemical tests. Microscopic analyses of plant 
are invaluable for assuring the identity of the material and as 
an initial screening test for impurities. Most manufacturers 
of herbal products lack the quality control personnel to 
accurately as identity and purity microscopically35.  
Chemical Evaluation Chemical analysis of the drug is done 
to assess the potency of vegetable material in terms of its 
active principles. It covers screening, isolation, identification, 
and purification of the chemical components. It help to 
determine the identity of the drug substance and possible 
adulteration36. 
Biological Evaluation Pharmacological activity of certain 
drugs has been applied to evaluate and standardize them. 
The assays on living animals and on their intact or isolated 
organs can indicate the strength of the drug or their 
preparations37. 
Analytical Methods- It helps in determining identity, 
quality and relative potency. The most important step in the 
development of analytical methods for botanical and herbal 
preparations is sample preparation38. The basic operation 
includes steps such as pre- washing, drying of plant 
materials or freeze drying d grinding, to obtain a 
homogenous sample and often improving the kinetics of 
extraction of the constituents. In the Pharmacopoeial 
monographs, method such as sonication, heating under 
reflux, Soxhlet extraction, and others are commonly used39-
40 However, such methods can be time-consuming, require 
the use of a large amount of organic solvent, and may have 
lower extraction efficiencies. 
Chromatography Separation of individual components 
from the herbal mixture is the key step to enable 
identification and bioactivity evaluation. TLC is used 
extensively in the phytochemical evaluation of herbal drugs 
because It enables rapid analysis of herbal extracts with 
minimum sample clean-up requirement, It provides 
qualitative and semi quantitative n formation of the resolved 
compounds. In TLC fingerprinting, the data that can be 
recorded using a high performance TLC (HPTLC) scanner 
includes the chromatogram, retardation factor (Rf) values, 
the color of the separated bands, their absorption spectra, λ 
max and shoulder inflection/s of all the resolved bands41. It 
has been well reported that several samples can be run 
simultaneously by use of a smaller quantity of mobile phase 
than in HPLC. HPTLC technique is widely employed in 
pharmaceutical Industry in process development, 
identification and detection of adulterants in herbal product 
and helps in identification of pesticide content, mycotoxins 
and in quality control of herbs and health foods. LC-MS has 
ecome method of choice in many stages of drug 
development42.  
METHODS OF STANDARDISATION OF AYURVEDIC 
MEDICINES 
1) Raw material standardization. 
2) In process standardization 
3) Finished product standardization. 
1. Raw material standardization: This includes 
authentification process in which following points should be 
considered. Area of the collection, parts of the plant 
collection, the regional situation, botanical identity, 
microscopic and histological analysis, taxonomic identity, 
Foreign matter, Loss on drying, swelling index, foaming 
index, ash values and extractive values, Chromatographic 
and spectroscopic evaluation, Determination of heavy 
metals, pesticide residues, Microbial contamination, 
Radioactive contamination43. 
2. In process standardization:-SOP’s it should have the 
manufacturing procedure in detail, if other substances are 
added during manufacture in order to adjust the plant 
preparation. A method for identification and, where possible, 
assay of the plant preparation should be added. If 
identification of an active principle is not possible, it should 
be sufficient to identify a characteristic substance or mixture 
of substances to ensure consistent quality of the 
preparation44. 
3. Final product:-Prepared drug should possess standard 
nature of characteristics. The manufacturing procedure and 
formula, including the amount of recipients, should be 
described in detail. A finished product specification should 
be defined to ensure consistent quality of the product. The 
finished product should comply with general requirements 
for particular dosage forms. The processes involves wide 
array of scientific investigations, which include physical, 
chemical and biological evaluation employing various 
analytical methods and tools. The specific aims of such 
investigation in assuring herbal quality are as varied as the 
processes employed45. 
 
Standerdization of Bhasmas Bhasmas are made from 
metals like zinc, lead, gold, silver, tin, copper, metal mixtures 
and alloys as also from gems, coral and mica and some other 
minerals, etc. These are formed by calcinations of the 
parents’ substances like minerals, etc. in a rigorous, 
prescribed manner after it has been appropriately purified 
and emasculated with herbal juices or minerals. These 
studies also explored intensively the different bhasmas 
reparation methods of the same metal, chemical nature and 
crystalline structure of the intermediates and the final 
products. From results on particle size distribution and 
crystal structure, one can determine how well the bhasma 
process has proceeded. With such equipment in hand, it 
should be possible to standardize and freeze the SOPs for 
bhasma preparations. A ten points protocol has been 
suggested for the standardization of bhasmas and the 
process of their preparations .A standardization programme 
should also distinguish between bhasmas of metals made of 
either herbs and non-toxic minerals and those with toxic 
substances46. 
Multiple Herbal formulations are obtained by subjecting 
herbal ingredients to various manufacturing process such as 
extraction, distillation, expression, fractions, partition, 
chromatography and formulations47.  
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 Toxicity in herbals and their interactions A part from 
efficacy, FDA is also charged with determining the safety of 
drug products, and not all botanicals/herbals harmless. In 
this context the reference to the incidence of 1991and 1992 
in Brussels, Belgium, In which 30 women treated with a 
Chinese herbal slimming preparation died from renal failure 
caused by the presence of aristocholic acid in it can be taken 
into account. One of the herbs had been incorrectly 
identified as a non-toxic. So the importance on controlling 
the correct identification of herbal preparations should be 
taken into account from very beginning. In addition to the 
problem of incorrect plant identification, some mixtures may 
be toxic, particularly if they are misused. Important should 
be given to continuous surveillance and of actively 
requesting information rather than just collecting reports 
and even this can be considered as national program48.  
DNA Fingerprinting Technique DNA analysis has been 
proved as an important tool in herbal drug standardization. 
This technique is useful for identification of phytochemically 
indistinguishable genuine drug from substituted or 
adulterated drug. It has been reported that DNA fingerprint 
genome remain the same irrespective of the plant part used 
while the Phytochemical content will vary with the plant 
part used, physiology and environment42 . This concept of 
fingerprinting has been increasingly applied in the past few 
decades to determine the ancestry of plants, animals and 
other micro-organisms. Genotypic characterization of plant 
species and strains is useful as most plants, though 
belonging to the same genus and species, may show 
considerable variation between strains. Additional 
motivation for using DNA fingerprinting on commercial 
herbal drugs is the availability of intact genomic DNA from 
plant samples after they are processed. Adulterants can be 
distinguished even in processed samples, enabling the 
authentication of the drug. The other useful application of 
DNA fingerprinting is the availability f intact genomic DNA 
specificity in commercial herbal drugs which helps in 
distinguishing adulterants even in processed samples49.  
Role Genetic Markers in Standardization: - RAPD based 
mole mcular markers have been found to be useful in 
differentiating different accessions of neem collected from 
different geographical regions. Germless analysis to study 
genetic diversity is another important area in which a lot of 
efforts have been put in. Fingerprinting of crops like rice 
wheat, chickpea, pigeon pea, pearlmillet etc is being carried 
out extensively. Sequence characterized amplified region 
(SCAR), AP– PCR, RAPD and RFLP have been successfully 
applied for differentiation of these plants and to detect 
substitution by other closely related species. e.g. P. ginseng 
is often substituted by P. quinquefolius (American 
ginseng).RAPD markers have been successively used for 
selection of micro propogated plants of Piper longum for 
conservation50. 
CONCLUSION 
The Indian herbal industry is growing in a tremendous rate. 
With the tremendous increase in traditional herbal therapy 
several concerns regarding the safety and quality of herbal 
medicines have also been observed. There is and for more 
advanced techniques of standardization. The advancement 
of analytical techniques will serve as a rapid and specific tool 
in the herbal research, thereby, allowing the manufacturers 
to set quality standards and specifications so as to seek 
marketing approval from regulatory authorities for 
therapeutic efficacy, safety and half-life of herbal drugs. The 
numerous examples of commercial product variability 
emphasize the need for continued effort towards more 
meaningful and effective standardization of herbal 
medicines, as well as regulatory programs for ensuring 
proper botanical identity, quality and strength of 
commercial products. 
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